Search results for: 'CHINA pharmaceutical market'

This research service sets the stage for visionary thinking by identifying the most important global Mega Trends in China, outlining the potential scenarios for specific trends in 2025, and providing the implications of these Mega Trends for transforming society, markets, and cultures. It focuses on 13 Mega Trends identified by Frost & Sullivan, in...

This research service discusses current and future potential of the Chinese electric vehicle (EV) industry. It provides a strategic overview of the Chinese EV market, including key technology trends, market drivers, and restraints for EVs and relevant charging infrastructure. Market size and forecasts of the EV market by OEM, model, and segment, as...

Business-to-business (B2B) influencer marketing has the potential to generate $11.7 billion in revenue by the end of 2022, with more than 38% of B2B companies currently exploring influencer marketing as a new lead-generation avenue. Influencer marketing is set to become a mainstream approach for B2B companies that are looking to tap into the power ...

The report provides an indepth analysis of each trend, outlining market demands, drivers and restraints, growth opportunities, and use cases. This will help vendors analyze the market, evaluate their market positioning, and take appropriate action to become global leaders.--BEGIN PROMO--Research Scope This study examines the market scenario and ...

24 Oct 2018  |  North America  |  Market Research

Growth Opportunities in the Global Cell Therapy Market, Forecast to 2025

A Robust Product Pipeline Creating Opportunities for Ground-breaking Combination Therapies is Set to Revolutionize the Global Cell Therapy Market

Infographics

×

Key Issues Addressed

The global pharmaceuticals industry is continuously evolving to meet the requirements of a changing disease landscape. With the increasing prevalence of chronic infectious diseases and cancer, market needs are shifting from traditional small molecules to novel large molecule therapies, with cell therapies dominating the space. This study presents a...

Marketing is changing rapidly. Customers are no longer driven by advertisements; instead, their purchase decisions are influenced by their favorite content creators. Moreover, owing to the growing time spent online and the increasing amount of content, the creator economy is changing the way marketing is done. In this study, Frost & Sullivan exp...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

23 Apr 2019  |  Global  |  Market Research

Growth Opportunities in the Stationary Fuel Cell Market, Forecasts to 2030

Increasing Acceptability and Falling Costs to Drive the Market for Fuel Cells

Infographics

×

Key Issues Addressed

Fuel cells are expected to see significant growth over the next decade, as countries move toward cleaner power to diversify their power mix away from fossil fuels. The market is expected to witness steady growth due to the construction and installation of fuel cell power by companies along with the declining cost of new/existing technologies, leadi...